[144] TechnipFMC plc SEC Filing

Rhea-AI Filing Summary

TechnipFMC plc (FTI) filed a Form 144 proposing the sale of 113,760 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $4,392,827.98. The filing states there are 411,016,473 shares outstanding, and the approximate date of sale is 09/22/2025. The shares to be sold were acquired mainly through restricted stock vesting on 02/21/2024 (8,851 shares), 02/20/2025 (6,749), 02/21/2025 (9,000) and 03/08/2025 (75,400), with two lots tied to options (6,584 and 7,176) dated to be sold on 09/22/2025 and paid in cash. The filer reports no securities sold in the past three months and certifies they have no undisclosed material information.

Positive

• Full disclosure of sale details including broker, number of shares, aggregate value, and estimated sale date
• No reported sales in the past three months, indicating this is not part of a recent selling pattern
• Acquisition sources are disclosed (restricted stock vesting and option-related lots), providing transparency on origins of the shares

Negative

• None.

Insights

Securities Analyst

TL;DR: Proposed insider sale equals 113,760 shares (~0.0277% of outstanding), a small, non-dilutive transaction but worth disclosure to investors.

The filing shows an insider intends to sell 113,760 common shares via a broker on 09/22/2025 with an aggregate value of $4.39 million based on the filers entry. Relative to the stated 411,016,473 shares outstanding, the sale represents approximately 0.0277% of the share base, indicating the transaction is immaterial to capital structure and unlikely to drive market-moving dilution. The underlying shares were predominantly acquired via restricted stock vesting and two option-related lots, with payment noted as compensation for vested grants and cash for option proceeds. No sales in the prior three months are reported, which provides context that this is an isolated planned sale rather than a pattern of recent disposals.

Corporate Governance Expert

TL;DR: Form 144 disclosure meets insider-sale transparency; the small size reduces governance concern but warrants routine monitoring.

The notice fulfills Rule 144 disclosure requirements by listing acquisition dates, transaction nature, amounts, broker information, and a representation about material nonpublic information. Most securities listed derive from restricted stock vesting (compensation) while two lots are linked to option exercises to be paid in cash. The filers certification that they are not aware of undisclosed material adverse information is standard and required. Given the sales immaterial percentage of outstanding shares, this report raises limited governance or market-impact concerns but should be tracked alongside future filings for any pattern of insider dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	113760	4392827.98	411016473	09/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/21/2024	Restricted Stock Vesting	Issuer			8851	02/21/2024	Compensation
Common	02/20/2025	Restricted Stock Vesting	Issuer			6749	02/20/2025	Compensation
Common	02/21/2025	Restricted Stock Vesting	Issuer			9000	02/21/2025	Compensation
Common	03/08/2025	Restricted Stock Vesting	Issuer			75400	03/08/2025	Compensation
Common	09/22/2025	Option Granted - 06/14/2018	Issuer			6584	09/22/2025	Cash
Common	09/22/2025	Option Granted - 06/26/2017	Issuer			7176	09/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TechnipFMC's Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 113,760 common shares through Fidelity on the NYSE with an aggregate market value of $4,392,827.98 and an approximate sale date of 09/22/2025.

How large is the proposed sale relative to outstanding shares of FTI?

Based on the filing's figures, 113,760 shares represent approximately 0.0277% of the 411,016,473 shares outstanding described in the notice.

Where did the shares being sold come from according to the filing?

The filing lists acquisitions from restricted stock vesting on 02/21/2024 (8,851), 02/20/2025 (6,749), 02/21/2025 (9,000), 03/08/2025 (75,400) and two option-related lots (6,584 and 7,176) tied to grants dated 2018 and 2017.

Did the filer report any securities sold in the prior three months?

The Form 144 indicates Nothing to Report for securities sold during the past three months.

Does the filer state they possess any undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information